ArticleScientific reports2026
Neurotoxicogenomic impact of 4-nonylphenol on Heteropneustes fossilis via molecular, histopathological and bioinformatic analysis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Exposure to 4-Nonylphenol at concentrations of 64 µg/L (low) and 160 µg/L (high) for 30 to 60 days, spanning the pre-spawning to spawning phases in H. fossilis, induces significant adverse effects in the brain, particularly within the telencephalon and cerebellum regions. Additionally, protein content in brain decreases in treated group of 4-Nonylphenol (4-NP), brain acetylcholinesterase (AChE) activity decreases in a manner contingent upon the amount of dose and exposure period. In the brain tissue of H. fossilis, exposure to 4-Nonylphenol (4-NP) results in a dose-dependent decrement of antioxidant enzymes including Superoxide dismutase(SOD), Catalase, and Glutathione peroxidase(GPx), alongside a dose and duration-dependent increase in Lipid peroxidation (LPO) levels. Cortisol level in the brain increases with higher doses of 4-NP. The exposure to 4-NP induces a dose-dependent increase in cell death after both 30 and 60 days, with a marked increase in necrosis after 30 days. However, at 60 days, apoptosis becomes more prominent, suggesting a shift toward programmed cell death due to prolonged exposure. In the brain cells of H. fossilis, exposure to 4-Nonylphenol (4-NP) over 30 to 60 days caused an escalation in reactive oxygen species (ROS) and DNA fragmentation. Gene expression of brain aromatase (Cyp19a1b) and Gonadotropin-releasing hormone (GnRH) is downregulated in a dose-dependent manner. These findings indicate that both acute and chronic exposure to 4-NP induces neurotoxicity in male H. fossilis by crossing the blood-brain barrier. This was further validated through an in silico analysis using SwissADME, which predicted high intestinal absorption of 4-NP and its potential to cross the blood-brain barrier. Additionally, molecular docking and Molecular Dynamics (MD) simulations substantiated a strong binding affinity of 4-NP to acetylcholinesterase in the brain. Overall, this investigation demonstrates that 4-NP disrupts brain tissue, impairs antioxidant defenses, promotes ROS production, and impacts gene expression and brain enzyme activity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.